-+ 0.00%
-+ 0.00%
-+ 0.00%

AN2 THERAPEUTICS INC - PHASE 2 STUDY EXPECTED TO BEGIN IN Q3 2026 WITH DATA READOUTS AS EARLY AS Q4 2026 AND THROUGHOUT 2027

Reuters·03/03/2026 21:00:00

Please log in to view news